Literature DB >> 8902076

Chemokine production in HIV-seropositive long-term asymptomatic individuals.

M Clerici, C Balotta, D Trabattoni, L Papagno, S Ruzzante, S Rusconi, M L Fusi, M C Colombo, M Galli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8902076     DOI： 10.1097/00002030-199610000-00019

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  14 in total

1.  Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

Authors:  A Garzino-Demo; R B Moss; J B Margolick; F Cleghorn; A Sill; W A Blattner; F Cocchi; D J Carlo; A L DeVico; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.

Authors:  L Sarmati; G d'Ettorre; E Nicastri; L Ercoli; I Uccella; P Massetti; S G Parisi; V Vullo; M Andreoni
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

3.  Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

Authors:  F Cocchi; A L DeVico; R Yarchoan; R Redfield; F Cleghorn; W A Blattner; A Garzino-Demo; S Colombini-Hatch; D Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Do beta-chemokines have clinical relevance in HIV infection?

Authors:  C E Mackewicz; E Barker; G Greco; G Reyes-Teran; J A Levy
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 5.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 6.  Chemokine receptors and chemokines in HIV infection.

Authors:  A Garzino-Demo; A L DeVico; R C Gallo
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

7.  The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.

Authors:  Carl E Mackewicz; Charles S Craik; Jay A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

8.  Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides.

Authors:  H Müller; G Mayer; B Behnke; E Heimüller; G Hamscher; D Immler; C Siethoff; H E Meyer; M Schreiber
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

9.  Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.

Authors:  K Grovit-Ferbas; J Ferbas; V Gudeman; S Sadeghi; M B Goetz; J V Giorgi; I S Chen; W A O'Brien
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression.

Authors:  Anuska Llano; Jordi Barretina; Arantxa Gutiérrez; Bonaventura Clotet; José A Esté
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.